ADXN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Addex Therapeutics Ltd (ADXN) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of significant positive catalysts, neutral trading sentiment, and weak financial performance suggest that waiting for clearer signals or better opportunities is prudent.
The MACD is positive but contracting, RSI is neutral at 54.826, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot point of 6.521, with resistance at 7.358 and support at 5.685.
NULL identified. No recent news or significant insider/hedge fund activity.
Revenue dropped by 7.97% YoY in Q3 2025, and the stock has shown a regular market decline of -2.71%.
In Q3 2025, revenue decreased by 7.97% YoY to 62014.92. Net income improved by 11.60% YoY but remains negative at -1972013.2. EPS and gross margin showed no change YoY.
No analyst rating or price target changes available.
